Results 261 to 270 of about 10,125,713 (289)
Some of the next articles are maybe not open access.
Current Diagnostic Pathology, 1998
Non-alcoholic steatohepatitis (NASH) has become recognized as a relatively common cause of abnormal liver function tests. It is defined by a combination of clinical features (excluding excess alcohol intake) and histopathological biopsy features which are indistinguishable from those of alcoholic hepatitis.
openaire +3 more sources
Non-alcoholic steatohepatitis (NASH) has become recognized as a relatively common cause of abnormal liver function tests. It is defined by a combination of clinical features (excluding excess alcohol intake) and histopathological biopsy features which are indistinguishable from those of alcoholic hepatitis.
openaire +3 more sources
Non-alcoholic steatohepatitis.
The Journal of the Association of Physicians of India, 2005Non-alcoholic steatohepatitis (NASH) represents only a part of a wide spectrum of non-alcoholic fatty liver disease (NAFLD) and its prevalence is only 2 - 3% in the general population. Obesity, diabetes, hyperlipidemia and female sex are important risk factors for NASH.
K, Das, P, Kar
openaire +1 more source
Statins and non-alcoholic steatohepatitis
Journal of Hepatology, 2016Vasilios G, Athyros +3 more
openaire +2 more sources
Statins and non-alcoholic steatohepatitis
Metabolism, 2017Vasilios G, Athyros +2 more
openaire +2 more sources
Non-alcoholic Steatohepatitis in Children
Clinics in Liver Disease, 2003Non-alcoholic steatohepatitis (NASH) is an important liver disease in children; it can cause cirrhosis in children. The disease mechanism involves hepatic insulin resistance with hyperinsulinemia and changes in certain adipocytokines and inflammatory mediators.
openaire +3 more sources
Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis
Journal of Hepatology, 2022Ling Lu, Haoming Zhou
exaly
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Nature Reviews Drug Discovery, 2016Giovanni Musso +2 more
exaly
How different is the dietary pattern in non-alcoholic steatohepatitis patients?
Clinical Nutrition, 2006Carla Lopes +2 more
exaly
Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice
Journal of Hepatology, 2020Xiaojing Wang, Kai Huang, Cheng Wang
exaly